235 related articles for article (PubMed ID: 21339739)
1. Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.
Dettman EJ; Simko SJ; Ayanga B; Carofino BL; Margolin JF; Morse HC; Justice MJ
Oncogene; 2011 Jun; 30(25):2859-73. PubMed ID: 21339739
[TBL] [Abstract][Full Text] [Related]
2. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
[TBL] [Abstract][Full Text] [Related]
3. A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL).
Carofino BL; Ayanga B; Justice MJ
Dis Model Mech; 2013 Nov; 6(6):1494-506. PubMed ID: 24046360
[TBL] [Abstract][Full Text] [Related]
4. The zinc finger SET domain gene Prdm14 is overexpressed in lymphoblastic lymphomas with retroviral insertions at Evi32.
Dettman EJ; Justice MJ
PLoS One; 2008; 3(11):e3823. PubMed ID: 19043588
[TBL] [Abstract][Full Text] [Related]
5. PRDM14 maintains pluripotency of embryonic stem cells through TET-mediated active DNA demethylation.
Okashita N; Sakashita N; Ito K; Mitsuya A; Suwa Y; Seki Y
Biochem Biophys Res Commun; 2015 Oct; 466(1):138-45. PubMed ID: 26325469
[TBL] [Abstract][Full Text] [Related]
6. Lymphoid progenitor cells from childhood acute lymphoblastic leukemia are functionally deficient and express high levels of the transcriptional repressor Gfi-1.
Purizaca J; Contreras-Quiroz A; Dorantes-Acosta E; Vadillo E; Arriaga-Pizano L; Fuentes-Figueroa S; Villagomez-Barragán H; Flores-Guzmán P; Alvarado-Moreno A; Mayani H; Meza I; Hernandez R; Huerta-Yepez S; Pelayo R
Clin Dev Immunol; 2013; 2013():349067. PubMed ID: 24198842
[TBL] [Abstract][Full Text] [Related]
7. PRDM14 Drives OCT3/4 Recruitment via Active Demethylation in the Transition from Primed to Naive Pluripotency.
Okashita N; Suwa Y; Nishimura O; Sakashita N; Kadota M; Nagamatsu G; Kawaguchi M; Kashida H; Nakajima A; Tachibana M; Seki Y
Stem Cell Reports; 2016 Dec; 7(6):1072-1086. PubMed ID: 27866876
[TBL] [Abstract][Full Text] [Related]
8. Mouse Lymphoblastic Leukemias Induced by Aberrant
Simko SJ; Voicu H; Carofino BL; Justice MJ
Cancers (Basel); 2012 Dec; 4(4):1050-1066. PubMed ID: 23487523
[TBL] [Abstract][Full Text] [Related]
9. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
Konantz M; André MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Leukemia; 2013 Jan; 27(1):56-65. PubMed ID: 22828445
[TBL] [Abstract][Full Text] [Related]
10. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
Sykes DB; Kamps MP
Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
[TBL] [Abstract][Full Text] [Related]
11. Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14.
Tracey LJ; Justice MJ
Trends Genet; 2019 Jul; 35(7):489-500. PubMed ID: 31130394
[TBL] [Abstract][Full Text] [Related]
12. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein kinase C increases Prdm14 level to promote self-renewal of embryonic stem cells through reducing Suv39h-induced H3K9 methylation.
Ji J; Cao J; Chen P; Huang R; Ye SD
J Biol Chem; 2024 Mar; 300(3):105714. PubMed ID: 38309502
[TBL] [Abstract][Full Text] [Related]
14. Immature B-cell progenitors survive oncogenic stress and efficiently initiate Ph+ B-acute lymphoblastic leukemia.
Signer RA; Montecino-Rodriguez E; Witte ON; Dorshkind K
Blood; 2010 Oct; 116(14):2522-30. PubMed ID: 20562326
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice.
Moriya C; Taniguchi H; Miyata K; Nishiyama N; Kataoka K; Imai K
Carcinogenesis; 2017 Jun; 38(6):638-648. PubMed ID: 28498896
[TBL] [Abstract][Full Text] [Related]
16. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
[TBL] [Abstract][Full Text] [Related]
17. Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both Down syndrome and non-Down syndrome genetic backgrounds.
Gant VU; Junco JJ; Terrell M; Rashid R; Rabin KR
PLoS One; 2021; 16(1):e0244863. PubMed ID: 33411777
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
Souabni A; Jochum W; Busslinger M
Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
[TBL] [Abstract][Full Text] [Related]
19. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
[TBL] [Abstract][Full Text] [Related]
20. miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
Malouf C; Antunes ETB; O'Dwyer M; Jakobczyk H; Sahm F; Landua SL; Anderson RA; Soufi A; Halsey C; Ottersbach K
Blood; 2021 Nov; 138(21):2066-2092. PubMed ID: 34111240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
